Search

Your search keyword '"Hepatitis B Surface Antigens genetics"' showing total 2,554 results

Search Constraints

Start Over You searched for: Descriptor "Hepatitis B Surface Antigens genetics" Remove constraint Descriptor: "Hepatitis B Surface Antigens genetics"
2,554 results on '"Hepatitis B Surface Antigens genetics"'

Search Results

1. Exploring the tolerable region for HiBiT tag insertion in the hepatitis B virus genome.

2. Structural basis for hepatitis B virus restriction by a viral receptor homologue.

3. Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.

4. Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic.

5. An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes.

6. Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process.

7. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9.

8. Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses.

9. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.

10. First Detection of Hepatitis B Virus Subgenotype A5, and Characterization of Occult Infection and Hepatocellular Carcinoma-Related Mutations in Latin American and African Immigrants in Brazil.

11. Association of HLA-DRB1 alleles with status of antibodies to hepatitis B surface and e antigen.

12. Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection.

13. Prevalence and molecular characteristics of occult hepatitis B virus infection among blood donors in Huzhou City, eastern China.

14. Exchanges in the 'a' determinant of the hepatitis B virus surface antigen revisited.

15. CRISPR-Cas13b-mediated suppression of HBV replication and protein expression.

16. The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study.

17. Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations.

18. Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic.

19. The Characteristic of HBV Quasispecies Is Related to Occult HBV Infection of Infants Born to Highly Viremic Mothers.

20. M133S mutation possibly involve in the ER stress and mitophagy pathway in maintenance hemodialysis patients with occult hepatitis B infection.

21. Hepatitis B Virus Genotypes and Subgenotypes Circulating in Infected Residents in a Country with High Vaccination Rate.

22. Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.

24. CRISPR/Cas9 System with Dual gRNAs Synergically Inhibit Hepatitis B Virus Replication.

25. Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection.

26. Analysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like Agents.

27. Genetic variability of hepatitis B virus in acute and in different phases of chronic infection in Brazil.

28. Frequency of HBsAg variants in occult hepatitis B virus infected patients and detection by ARCHITECT HBsAg quantitative.

29. Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription.

30. [Study on mechanism of Chinese Yam polysaccharide synergizing nucleoside analogues against hepatitis B virus through p38 MAPK signaling pathway].

31. Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States.

32. Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients.

33. Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022.

34. Mathematical Models of Early Hepatitis B Virus Dynamics in Humanized Mice.

35. Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss.

36. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection.

37. Comprehensive analysis of antigenic variations and genomic properties of hepatitis B virus in clinical samples in the mid-north east region of Bangladesh.

39. The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.

40. HBsAg level defines different clinical phenotypes of HBeAg(-) chronic HBV infection related to HBV polymerase-specific CD8 + cell response quality.

41. Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers.

42. Juveniles, young adults, and infants with hepatitis B virus infection: A genomic study.

43. PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation.

44. Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161.

45. Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells.

46. Cytokines Expression Compared to the Determinants of Cellular Apoptosis Prominently Attributes to the Deleterious Effects of 'A' Determinant Surface Gene Mutations in HBV Transfected Hepatoma Cell Line.

47. Distribution and Clinical Significance of Hepatitis B virus A1762T/G1764A Double Mutation in Chronic Hepatitis B Patients: A Cross-Sectional Study.

48. Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B.

49. Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication.

50. Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy.

Catalog

Books, media, physical & digital resources